Lizhu J. Lin
No. 16 Airport Road
Guangzhou, 510405, China
Guangzhou, 510405, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 155 publications
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial.
Journal: BMJ (Clinical research ed.)
Published: March 12, 2026
First-Line Tislelizumab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Cancer: Three-Year Follow-Up of the Phase 3 RATIONALE-309 Randomized Clinical Trial.
Journal: JAMA oncology
Published: February 26, 2026
DOT1L promotes immune evasion in lung adenocarcinoma through H3K79me2-mediated epigenetic activation of immune checkpoints.
Journal: Frontiers in immunology
Published: October 06, 2025
Chlorogenic Acid Regulates Macrophage Polarization in LUAD by Inhibiting Taurodeoxycholic Acid Metabolism to Block the TGR5/STAT3 Signaling Pathway.
Journal: Phytotherapy research : PTR
Published: September 10, 2025
Anti-lung cancer therapy using nano-assembly particles of traditional Chinese Medicine formula.
Journal: Materials today. Bio
Published: August 14, 2025
Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP/ANKRD1 axis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 05, 2025
KLF16-induced Increase of GARS Promotes Glycolysis in Hepatocellular Carcinoma by Stabilizing FOXK1.
KLF16-induced Increase of GARS Promotes Glycolysis in Hepatocellular Carcinoma by Stabilizing FOXK1.
Journal: The Tohoku journal of experimental medicine
Published: July 02, 2025
Clinical Study on the Prevention of High-Risk Pulmonary Nodule Progression With Yifei Sanjie Pill: Protocol for a Multicenter Randomized Controlled Trial.
Journal: JMIR research protocols
Published: June 04, 2025
External Application of a Xiaozhen zhiyang Decoction for Facial Rash Related to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Chinese Patients: A Prospective Single-Arm Observational Study.
Journal: Integrative cancer therapies
Published: May 17, 2025
Immunotherapy Safety in Thymic Epithelial Tumors: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System.
Journal: JMIR cancer
Published: May 04, 2025
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Journal: Nature medicine
Published: March 27, 2025
Last Updated: 09/26/2026